Pomalyst Oral Capsule 1Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

POMALYST: Oral capsule (1mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

POMALIDOMIDE (pom a LID oh mide) is a chemotherapy drug used to treat multiple myeloma. It targets specific proteins within cancer cells and stops the cancer cell from growing.

In-Depth Information

POMALYST 1mg Capsule

NDC: 595720501
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Multiple Myeloma

Storage Information
Store between 59 to 77 degrees F, excursions permitted to 59 to 86 degrees F
POMALYST 1mg Capsule

Reported Side Effects for POMALYST 1mg Capsule

Low Blood Sodium Levels Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Blood Clot In Lung Incidence:
<4.7%*
Severity: SEVERE
Onset: DELAYED
Shaking Incidence:
<0.7%*
Severity: SEVERE
Onset: EARLY
Increased Blood Sugar Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Infection Incidence:
<28.6%*
Severity: SEVERE
Onset: DELAYED
Muscle Cramps Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Heart Attack Incidence:
<3.0%*
Severity: SEVERE
Onset: DELAYED
Brain Attack Incidence:
<3.0%*
Severity: SEVERE
Onset: EARLY
Secondary Malignancy Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Muscle And/Or Bone Pain Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Skin Rash Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Blood Clot Incidence:
<4.7%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Joint Pain Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Bone Pain Incidence:
<7.3%*
Severity: SEVERE
Onset: DELAYED
Constipation Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Cough Incidence:
<0.7%*
Severity: SEVERE
Onset: DELAYED
Loose Stools Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Fever Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Headache Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Low Potassium Levels Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Low Calcium Levels Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
High Calcium Levels Incidence:
0.9%*
Severity: SEVERE
Onset: DELAYED
Decreased Appetite Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Low Lymphocytes Incidence:
1.0-7.1%*
Severity: SEVERE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
1.0-1.7%*
Severity: SEVERE
Onset: DELAYED
Lightheadedness Incidence:
>1.0%*
Severity: SEVERE
Onset: EARLY
Vomiting Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Pelvic Pain Incidence:
1.3%*
Severity: SEVERE
Onset: DELAYED
Fluid Retention Incidence:
1.3%*
Severity: SEVERE
Onset: DELAYED
Anemia Incidence:
1.4-21.4%*
Severity: SEVERE
Onset: DELAYED
Nerve Pain Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
2.7-9.8%*
Severity: SEVERE
Onset: DELAYED
Confusion Incidence:
3.0%*
Severity: SEVERE
Onset: EARLY
Weakness Incidence:
3.6%*
Severity: SEVERE
Onset: EARLY
Low White Blood Cells Incidence:
4.7-48.3%*
Severity: SEVERE
Onset: DELAYED
Back Pain Incidence:
5.0-9.8%*
Severity: SEVERE
Onset: DELAYED
Excessive Sweating Incidence:
5.0-16.1%*
Severity: MILD
Onset: DELAYED
Dehydration Incidence:
5.4%*
Severity: SEVERE
Onset: DELAYED
Shortness Of Breath Incidence:
5.7-12.5%*
Severity: SEVERE
Onset: EARLY
Nervousness Incidence:
7.1%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
7.3-8.9%*
Severity: MILD
Onset: RAPID
Blood Clot Incidence:
8.0%*
Severity: SEVERE
Onset: DELAYED
Weakness Incidence:
8.7-17.0%*
Severity: SEVERE
Onset: DELAYED
Tired Incidence:
8.7-17.0%*
Severity: SEVERE
Onset: EARLY
Weight Loss Incidence:
8.9%*
Severity: MILD
Onset: DELAYED
Kidney Failure Incidence:
10.3-12.5%*
Severity: SEVERE
Onset: DELAYED
Nose Bleed Incidence:
10.7%*
Severity: MILD
Onset: DELAYED
Weight Gain Incidence:
10.7%*
Severity: MILD
Onset: DELAYED
Dry Skin Incidence:
10.7%*
Severity: MILD
Onset: DELAYED
Chills Incidence:
12.5%*
Severity: MILD
Onset: EARLY
Night Sweats Incidence:
12.5%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
16.1%*
Severity: MILD
Onset: EARLY
Low Platelet Count Incidence:
18.8-22.0%*
Severity: SEVERE
Onset: DELAYED
Chest Pain Incidence:
19.6%*
Severity: MODERATE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for POMALYST 1mg Capsule

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Grapefruit juice and POMALYST 1mg Capsule(Pomalidomide)
Grapefruit juice and Pomalidomide(Pomalidomide)
Do not take grapefruit juice without talking to your health care professional. Avoid grapefruit juice during pomalidomide treatment if possible. Taking pomalidomide with grapefruit juice may increase the levels of pomalidomide in your body, especially if you are taking certain other medicines. This may increase the risk for side effects such as low blood cell counts, increased risk of bleeding, fatigue, constipation / diarrhea, and nausea.
Moderate Lifestyle Interaction
Tobacco and POMALYST 1mg Capsule(Pomalidomide)
Tobacco and Pomalidomide(Pomalidomide)
If you smoke cigarettes, talk to your health care professional. Smoking cigarettes while taking pomalidomide may decrease pomalidomide levels, causing therapy to not work as well for you.
Pregnancy & Lactation Information
FIRST Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

SECOND Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

THIRD Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with POMALYST

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.